HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
P/E ratio for HeartBeam, Inc. (BEAT)
P/E ratio as of 2023: -3.26
According to HeartBeam, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.26. At the end of 2022 the company had a P/E ratio of -3.11.
P/E ratio history for HeartBeam, Inc. from 2003 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -3.26 |
| 2022 | -3.11 |
| 2021 | -3.65 |
| 2020 | -436.73 |
| 2019 | -486.05 |
| 2018 | 49.91 |
| 2017 | -56.94 |
| 2016 | 11.68 |
| 2015 | 42.64 |
| 2014 | -27.08 |
| 2013 | -27.71 |
| 2012 | -4.66 |
| 2011 | -0.94 |
| 2010 | -5.68 |
| 2009 | -6.90 |
| 2008 | 49.14 |
| 2007 | -143.76 |
| 2006 | -6.73 |
| 2005 | -4.38 |
| 2004 | -2.41 |
| 2003 | -3.38 |